Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors

Therapeutic drug monitoring (TDM) is uncommon in child and adolescent psychiatry, particularly for selective serotonin reuptake inhibitors (SSRIs)—the first-line pharmacologic treatments for depressive and anxiety disorders. However, TDM in children and adolescents offers the opportunity to leverage...

Descripción completa

Detalles Bibliográficos
Autores principales: Strawn, Jeffrey R., Poweleit, Ethan A., Uppugunduri, Chakradhara Rao S., Ramsey, Laura B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517085/
https://www.ncbi.nlm.nih.gov/pubmed/34658889
http://dx.doi.org/10.3389/fphar.2021.749692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517085/
https://www.ncbi.nlm.nih.gov/pubmed/34658889
http://dx.doi.org/10.3389/fphar.2021.749692

Ejemplares similares